| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 45.69M | — |
| Operating expense | — | — |
| Net income | -39.11M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 6A3A.F returned +32.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +24.7% |
| 1 year | +32.0% |
| 5 years | -64.1% |
| All-time high | €34.15 (Nov 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 6A3A.F would be worth today ›No. Autolus Therapeutics plc has not paid a dividend in the past 12 months.
Autolus Therapeutics plc is part of the Healthcare sector.
Autolus Therapeutics plc has a market cap of 529.66M EUR, based on the latest quote.
Autolus Therapeutics plc is expected to report earnings around Nov 16, 2026. That date is an estimate and has not been confirmed by the company.
